P351: DOSE-ADJUSTED EPOCH + INOTUZUMAB OZOGAMICIN (DA-EPOCH-INO) IS SAFE AND ACTIVE IN ADULTS WITH RELAPSED/REFRACTORY (R/R) B LYMPHOBLASTIC LEUKEMIA (B-ALL): INITIAL RESULTS OF A PHASE I TRIAL

• R. Cassaday,
• K.-L. Garcia,
• T. Gooley,
• C. Martino,
• M.-E. Percival,
• A. Halpern,
• V. Oehler,
• J. Abkowitz,
• R. Walter,
• C. Ghiuzeli,
• E. Estey

Affiliations

R. Cassaday

1 University of Washington

K.-L. Garcia

1 University of Washington

T. Gooley

2 Fred Hutchinson Cancer Research Center

C. Martino

3 Seattle Cancer Care Alliance, Seattle, United States of America

M.-E. Percival

1 University of Washington

A. Halpern

1 University of Washington

V. Oehler

1 University of Washington

J. Abkowitz

1 University of Washington

R. Walter

1 University of Washington

C. Ghiuzeli

1 University of Washington

E. Estey

1 University of Washington